CCL21 and breast carcinoma: COX-2 is a major driver of human breast cancer progression and metastasis2–6 via activation of the PGE receptor EP418,19,21,22, leading to SLC-stimulation22,23 and induction of an oncogenic and SLC-promoting miRNA miR526b37.